These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. RE: Germline Mutations in Shelterin Complex Genes Are Associated With Familial Glioma. Cooke JG J Natl Cancer Inst; 2015 Aug; 107(8):. PubMed ID: 26079288 [No Abstract] [Full Text] [Related]
6. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia. Speedy HE; Kinnersley B; Chubb D; Broderick P; Law PJ; Litchfield K; Jayne S; Dyer MJS; Dearden C; Follows GA; Catovsky D; Houlston RS Blood; 2016 Nov; 128(19):2319-2326. PubMed ID: 27528712 [TBL] [Abstract][Full Text] [Related]
7. Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood. Michler P; Schedel A; Witschas M; Friedrich UA; Wagener R; Mehtonen J; Brozou T; Menzel M; Walter C; Nabi D; Pearce G; Erlacher M; Göhring G; Dugas M; Heinäniemi M; Borkhardt A; Stölzel F; Hauer J; Auer F Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769003 [TBL] [Abstract][Full Text] [Related]
8. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma. Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141 [TBL] [Abstract][Full Text] [Related]
9. Telomere-lengthening germline variants predispose to a syndromic papillary thyroid cancer subtype. DeBoy EA; Nicosia AM; Liyanarachchi S; Iyer SS; Shah MH; Ringel MD; Brock P; Armanios M Am J Hum Genet; 2024 Jun; 111(6):1114-1124. PubMed ID: 38688277 [TBL] [Abstract][Full Text] [Related]
10. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms. Lim TL; Lieberman DB; Davis AR; Loren AW; Hausler R; Bigdeli A; Li Y; Powers J; Raper A; Regeneron Genetics Center ; Carty SA; Nathanson KL; Bagg A; Hexner EO; Maxwell KN; Morrissette JJD; Babushok DV Leukemia; 2022 Jan; 36(1):283-287. PubMed ID: 34193977 [No Abstract] [Full Text] [Related]
11. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer. Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474 [TBL] [Abstract][Full Text] [Related]
12. Elucidating the molecular pathogenesis of glioma: integrated germline and somatic profiling of a familial glioma case series. Jacobs DI; Fukumura K; Bainbridge MN; Armstrong GN; Tsavachidis S; Gu X; Doddapaneni HV; Hu J; Jayaseelan JC; Muzny DM; Huse JT; Bondy ML Neuro Oncol; 2018 Nov; 20(12):1625-1633. PubMed ID: 30165405 [TBL] [Abstract][Full Text] [Related]
13. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Shi J; Yang XR; Ballew B; Rotunno M; Calista D; Fargnoli MC; Ghiorzo P; Bressac-de Paillerets B; Nagore E; Avril MF; Caporaso NE; McMaster ML; Cullen M; Wang Z; Zhang X; ; ; ; Bruno W; Pastorino L; Queirolo P; Banuls-Roca J; Garcia-Casado Z; Vaysse A; Mohamdi H; Riazalhosseini Y; Foglio M; Jouenne F; Hua X; Hyland PL; Yin J; Vallabhaneni H; Chai W; Minghetti P; Pellegrini C; Ravichandran S; Eggermont A; Lathrop M; Peris K; Scarra GB; Landi G; Savage SA; Sampson JN; He J; Yeager M; Goldin LR; Demenais F; Chanock SJ; Tucker MA; Goldstein AM; Liu Y; Landi MT Nat Genet; 2014 May; 46(5):482-6. PubMed ID: 24686846 [TBL] [Abstract][Full Text] [Related]
14. POT1: a genetic link for familial glioma. Bagcchi S Lancet Oncol; 2015 Jan; 16(1):e12. PubMed ID: 25524796 [No Abstract] [Full Text] [Related]
15. POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families. Potrony M; Puig-Butille JA; Ribera-Sola M; Iyer V; Robles-Espinoza CD; Aguilera P; Carrera C; Malvehy J; Badenas C; Landi MT; Adams DJ; Puig S Br J Dermatol; 2019 Jul; 181(1):105-113. PubMed ID: 30451293 [TBL] [Abstract][Full Text] [Related]
16. The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants. Gong Y; Stock AJ; Liu Y Curr Opin Genet Dev; 2020 Feb; 60():48-55. PubMed ID: 32155570 [TBL] [Abstract][Full Text] [Related]
17. POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma. Jalali A; Yu K; Beechar V; Bosquez Huerta NA; Grichuk A; Mehra D; Lozzi B; Kong K; Scott KL; Rao G; Bainbridge MN; Bondy ML; Deneen B Cancer Res; 2021 May; 81(10):2703-2713. PubMed ID: 33782098 [TBL] [Abstract][Full Text] [Related]
18. A Truncating Germline Mutation of He H; Li W; Comiskey DF; Liyanarachchi S; Nieminen TT; Wang Y; DeLap KE; Brock P; de la Chapelle A Thyroid; 2020 Feb; 30(2):204-213. PubMed ID: 31928178 [No Abstract] [Full Text] [Related]
19. Structural insights into POT1-TPP1 interaction and POT1 C-terminal mutations in human cancer. Chen C; Gu P; Wu J; Chen X; Niu S; Sun H; Wu L; Li N; Peng J; Shi S; Fan C; Huang M; Wong CC; Gong Q; Kumar-Sinha C; Zhang R; Pusztai L; Rai R; Chang S; Lei M Nat Commun; 2017 Apr; 8():14929. PubMed ID: 28393832 [TBL] [Abstract][Full Text] [Related]
20. POT1 tumour predisposition: a broader spectrum of associated malignancies and proposal for additional screening program. Baptista Freitas M; Desmyter L; Badoer C; Smits G; Vandernoot I; T Kint de Roodenbeke D Eur J Hum Genet; 2024 Aug; 32(8):980-986. PubMed ID: 38839987 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]